Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort

BACKGROUND: Major depressive disorder (MDD) is a complex disorder with a significant public health burden. Depression remission is often associated with weight gain, a major risk factor for metabolic syndrome (MetS). The primary objective of our study was to assess prospectively the impact of respon...

Descripción completa

Detalles Bibliográficos
Autores principales: El Asmar, K., Annan, N. B., Khoury, R., Colle, R., Martin, S., Ghoul, T. E., Trabado, S., Chanson, P., Feve, B., Verstuyft, C., Becquemont, L., Corruble, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600935/
https://www.ncbi.nlm.nih.gov/pubmed/36628576
http://dx.doi.org/10.1017/S0033291722003919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600935/
https://www.ncbi.nlm.nih.gov/pubmed/36628576
http://dx.doi.org/10.1017/S0033291722003919

Ejemplares similares